Latest Form 4 insider transactions

NASDAQ
Douglas A Haines, Reg. Pres. of West. OK & KS of Bank7 Corp., received 2,500 shares of common stock on July 29, 2026.
NASDAQ
Anat Cohen-Dayag, a Director of Compugen Ltd, received 100,000 shares of common stock on July 29, 2026.
NASDAQ
Danyl R Freeman, Chief Human Resources Officer of Burke & Herbert Financial Services Corp., reported multiple transactions in common stock on July 29, 2026.
NASDAQ
Henry Litchfield, VP; General Counsel of Bank7 Corp., received 2,500 shares of common stock on July 29, 2026.
NASDAQ
Eran Perry, a Director of Compugen Ltd, reported multiple transactions in common stock on July 29, 2026.
NASDAQ
George W. Cummings Iii, a Director of Business First Bancshares, Inc., sold 20,000 shares of common stock on July 28, 2026.
NASDAQ
Jason E Estes, Exec. Vice President; CCO of Bank7 Corp., reported multiple transactions in common stock on July 29, 2026.
NASDAQ
Pierre Ferre, Chief Operating Officer of Compugen Ltd, received 70,000 shares of common stock on July 29, 2026.
NASDAQ
Paul J Plante, a Director of Richardson Electronics, Ltd., sold 17,000 shares of common stock on July 28, 2026.
NASDAQ
Robert Langer, a Director of Seer, Inc., reported multiple transactions in common stock on July 28, 2026.
NASDAQ
Mark Andrew Warner, See Remarks* of Sei Investments Co, sold 15,000 shares of common stock on July 28, 2026.
NASDAQ
Kelly J Harris, EVP; CFO of Bank7 Corp., reported multiple transactions in common stock on July 29, 2026.
NASDAQ
Robert Edward Moritz Jr., a Director of Northern Trust Corp, purchased 255 shares of common stock on July 29, 2026 for $179.57 per share.
NASDAQ
Russo Sharon Kredo, SVP, Research & Discovery of Compugen Ltd, reported multiple transactions in common stock on July 29, 2026.
NASDAQ
LivePerson announces an investor webcast on August 5th to address stockholder questions and encourage a FOR vote on the proposed transaction with SoundHound AI.
NASDAQ
Michael Peterson, Executive Vice President of Sei Investments Co, sold 25,000 shares of common stock on July 28, 2026 for $102.05 per share.
NASDAQ
Thomas L Travis, President & CEO and a Director of Bank7 Corp., reported multiple transactions in common stock on July 29, 2026.
NASDAQ
RTW Fund Group GP, LLC and 1 other reported changes in beneficial ownership of VYNE Therapeutics Inc. common stock on July 29, 2026.
NASDAQ
Darrell Lee Mathews Jr., Executive Vice President of Bank7 Corp., received 3,500 shares of common stock on July 29, 2026.
Anupam Dalal, a Director of Aadi Bioscience, Inc., reported multiple transactions in common stock on May 14, 2026.
NASDAQ
Mathias Hukkelhoven, a Director of Compugen Ltd, reported multiple transactions in common stock on July 29, 2026.
NASDAQ
Edward Patrick Gray, a Director of Bank7 Corp., received 866 shares of common stock on July 29, 2026.
OTC.Pink
Vireo Growth Inc. has entered into a definitive agreement to acquire Planet 13 Holdings Inc. through a merger, with Planet 13 shareholders receiving a specified ratio of Vireo shares.
OQX
Vireo Growth Inc. has entered into a definitive agreement to acquire Planet 13 Holdings Inc. through a merger, with Planet 13 shareholders receiving a specified ratio of Vireo shares.
NASDAQ
Gilead Halevy, a Director of Compugen Ltd, reported multiple transactions in common stock on July 29, 2026.
NASDAQ
Stephen P. Carey, SVP & CFO of Ani Pharmaceuticals Inc, sold 2,850 shares of common stock on July 29, 2026 for $81.36 per share.
NASDAQ
Barry M Gosin, Chief Executive Officer of Newmark Group, Inc., reported a transaction in 300,000 shares of common stock on July 29, 2026.
NASDAQ
Gary D Whitcomb, a Director of Bank7 Corp., received 823 shares of common stock on July 29, 2026.
NASDAQ
Sanford S Zweifach, a Director of Compugen Ltd, reported multiple transactions in common stock on July 29, 2026.
NASDAQ
Teresa L. Dick, a Director of Bank7 Corp., received 769 shares of common stock on July 29, 2026.